On behalf of the Board of Directors, I invite you to attend the 49th Annual Meeting of the American College of Mohs Surgery taking place in San Francisco from Thursday, April 27 through Sunday, April 30, 2017 at the Hilton San Francisco Union Square.
The Scientific Program Committee has worked to craft a program that focuses on the varied topics you’ve indicated a desire to learn more about, from closures and reconstruction techniques to lab management and Mohs for melanoma, to name just a few.
As the meeting approaches, I urge you consider not only its educational value, but also its relational value. It’s no secret that ever since our time in residency and fellowship training programs, we’ve learned as much or perhaps more from each other as we have from myriad meetings, certification exams, or case studies in the literature. The Annual Meeting is one of the few times we have each year to reconnect with our colleagues, discuss important issues facing our practices and the specialty, and remember what every little tip and trick learned adds up to: Better patient care. Better outcomes. Better lives.
While it’s true that attending the Annual Meeting at least once every three years is a requirement of membership, we also know it’s much more than that. The interaction we share at the meeting makes us better surgeons but also makes us stronger members of the College, who better understand the issues facing our specialty and the house of medicine as a whole.
I want to offer my sincere thanks to Michel McDonald, chair of the Scientific Program Committee, for leading the development of a curriculum that includes something for everyone. Thanks also to Jeremy Bordeaux and his CME and Education Committee for their planning contributions, and to the ACMS staff for their deeply appreciated work on so many details.
Just as there has been a steady rise in the incidence of skin cancer nationwide, so has there been a rise in the number of available treatment options. We know it, referring physicians know it, and increasingly informed patients know it. There has never been a more important time than now to showcase how and why Mohs surgery is the gold standard for skin cancer treatment. We do this by coming together, learning, and carrying that knowledge into the field as ambassadors.
I hope you’ll join me, the Board of Directors, the hardworking committee and task force members, staff, and colleagues in San Francisco for what will be another great Annual Meeting.
Thomas Stasko, MD, FACMS
ACMS President, 2016-17
5: Pre-registration & hotel room block open
12: Abstract submission deadline
15: Fellows-in-Training Clinicopathological
Case Competition submission deadline
16: Early meeting registration ends
3: Exhibit booths must be paid in full
24: Hotel room block closes
31: Pre-registration ends; must register
onsite after this date
31: No Exhibitor refunds after this date
27-30: Annual Meeting